Nigerian-German Chemicals PLC manufactures and distributes specialty industrial chemicals and pharmaceuticals.
Price History & Performance
|Historical stock prices|
|Current Share Price||₦3.62|
|52 Week High||₦0|
|52 Week Low||₦0|
|1 Month Change||0%|
|3 Month Change||0%|
|1 Year Change||0%|
|3 Year Change||0%|
|5 Year Change||0%|
|Change since IPO||10.37%|
Recent News & Updates
|NIG-GERMAN||NG Pharmaceuticals||NG Market|
Return vs Industry: NIG-GERMAN underperformed the NG Pharmaceuticals industry which returned 39.5% over the past year.
Return vs Market: NIG-GERMAN underperformed the NG Market which returned 40.4% over the past year.
Stable Share Price: NIG-GERMAN is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: NIG-GERMAN's weekly volatility (0%) has been stable over the past year.
About the Company
Nigerian-German Chemicals PLC manufactures and distributes specialty industrial chemicals and pharmaceuticals. It also provides agrochemicals, such as herbicides, fungicides and insecticides; household consumer products, including disinfectants, insecticides, detergents, bleaches, personal care products, hygiene products, and air fresheners; veterinary/animal healthcare products consisting of anthelmintics, ecto-parasite remedies, anti-infectives, anti rabies vaccines, and fed additives; and oil and gas products comprising demulsifiers, flow improvers, biocides, corrosion inhibitors, flocculants, wax inhibitors, and scale inhibitors. The company was founded in 1963 and is based in Ota, Nigeria.
Nigerian-German Chemicals Fundamentals Summary
|NIG-GERMAN fundamental statistics|
Is NIG-GERMAN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NIG-GERMAN income statement (TTM)|
|Cost of Revenue||₦1.61b|
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
|Earnings per share (EPS)||0|
|Net Profit Margin||0.00%|
How did NIG-GERMAN perform over the long term?See historical performance and comparison
Is Nigerian-German Chemicals undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Nigerian-German Chemicals is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nigerian-German Chemicals has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is Nigerian-German Chemicals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nigerian-German Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Nigerian-German Chemicals performed over the past 5 years?
Historical Pharmaceuticals & Biotech annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Nigerian-German Chemicals has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
How is Nigerian-German Chemicals's financial position?
In this section we usually analyse Nigerian-German Chemicals's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Nigerian-German Chemicals has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
What is Nigerian-German Chemicals's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NIG-GERMAN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NIG-GERMAN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NIG-GERMAN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NIG-GERMAN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NIG-GERMAN's dividend in 3 years as they are not forecast to pay a notable one for the NG market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Adeboye Shonekan has been the Chief Executive Officer at Nigerian-German Chemicals PLC since April 27, 1999. Mr. Shonekan joined Nigerian-German in 1995 as an Executive Director and was responsible for...
Experienced Management: NIG-GERMAN's management team is seasoned and experienced (22.5 years average tenure).
Experienced Board: NIG-GERMAN's board of directors are seasoned and experienced ( 11.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Nigerian-German Chemicals PLC's employee growth, exchange listings and data sources
- Name: Nigerian-German Chemicals PLC
- Ticker: NIG-GERMAN
- Exchange: NGSE
- Founded: 1963
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₦556.705m
- Shares outstanding: 153.79m
- Website: https://www.ngc.ng
- Nigerian-German Chemicals PLC
- Km 38, Lagos-Abeokuta Expressway
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/21 20:59|
|End of Day Share Price||2021/10/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.